Nymox Pharmaceutical Corporation (NYMX) Stock Ratings

View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:

Not Rated

No Current Ratings
View All-Time Ratings

Other Member Ratings

View Most Rated Stocks

Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
Biotech_Invest Biotech_Invest 08/21/2015 1 Year $2.13 $2.46 +15.76% 15 Ended
Comments: NYMX BPD drug can generate billion sales after FDA approval (total sales of Flomax were about $2.1B)
heraklestrading heraklestrading 07/31/2015 3 months $2.56 $2.91 +13.67% 13 Ended
Comments: NDA submission imminent FDA approval very likely, overwhelming Phase III safety and efficacy results
Fizzled Fizzled 04/08/2015 1 week $1.35 $1.05 -22.22% -22 Ended
MarSarAsh MarSarAsh 03/18/2014 3 months $5.35 $4.91 -8.22% -8 Ended
Comments: $1.5 Billion dollar market once NX-1207 is approved
quiborum quiborum 07/24/2011 3 months $8.99 $6.74 -25.03% -25 Ended
Comments: Upcoming product launch will be successful

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.